Browsing: Approval

Eli Lilly on Thursday said it will file for approval of its next-generation obesity drug in the first quarter of 2027, as the treatment succeeds in two more late-stage trials. 

Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of Wegovy (semaglutide 25 mg) for adults with obesity and at least one weight-related comorbidity. The approval expands the company’s obesity franchise across Europe, making Wegovy the first GLP-1 tablet approved for weight management in the EU and…

Novo Nordisk NVO received a boost after the European Commission (EC) approved once-daily oral version of Wegovy (semaglutide 25 mg) for the treatment of adults with obesity, with at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity

|| Oh Yu-kyoung, Commissioner of the Ministry of Food and Drug Safety, speaks during a ministry work report held at the Blue House guest house on the 16th. Captured from the KTV National Broadcasting YouTube.

Novo Nordisk has received approval for its weight-loss pill, Wegovy, from the European Commission, which has also given the green light for the marketing of a high-dose version of the weight-loss drug as an injection, Novo Nordisk announced in a filing with the stock exchange

July 15 (Reuters) – Novo Nordisk said on Wednesday the European Commission approved its once-daily Wegovy pill for weight management in adults with obesity or who are overweight, making it the first oral GLP-1 weight-loss treatment cleared for use across the European Union

Health Canada’s recent approval of weight loss drug Zepbound as a treatment for obstructive sleep apnea in obese adults could create financial risks for benefits plan sponsors, says Joseph Koo, assistant vice-president of health solutions and national pharmacist at Aon